COVID-19 disease and immune dysregulation

被引：36

作者：

Davitt, Ethan ^{[1
]}

Davitt, Colin ^{[2
]}

Mazer, Monty B. ^{[3
,5
]}

Areti, Sathya S. ^{[4
]}

Hotchkiss, Richard S. ^{[1
,2
]}

Remy, Kenneth E. ^{[2
,3
,4
,5
,6
]}

机构：

[1] Washington Univ, Sch Med, St Louis, MO USA

[2] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO USA

[3] Univ Hosp Cleveland, Dept Pediat, Cleveland, OH USA

[4] Univ Hosp Cleveland, Dept Internal Med, Cleveland, OH USA

[5] Case Western Reserve Univ, Sch Med, Cleveland, OH USA

[6] Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Internal Med, 11100 Euclid Ave, Cleveland, OH 44106 USA

来源：

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 2022年 / 35卷 / 03期

基金：

美国国家卫生研究院;

关键词：

COVID-19; SARS-CoV-2; Immunology; Host immune response; Innate; Adaptive; COMPLEMENT ACTIVATION; INFECTION;

D O I：

10.1016/j.beha.2022.101401

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The SARS-CoV-2 virus has complex and divergent immune alterations in differing hosts and over disease evolution. Much of the nuanced COVID-19 disease immune dysregulation was originally dominated by innate cytokine changes, which has since been replaced with a more complex picture of innate and adaptive changes characterized by simultaneous hyperinflammatory and immunosuppressive phenomena in effector cells. These intricacies are summarized in this review as well as potential relevance from acute infection to a multisystem inflammatory syndrome commonly seen in children. Additional consideration is made for the influence of variant to variant host cellular changes and the impact of potential vaccination upon these phenotypes. Finally, therapeutic benefit for immune alterations are discussed.

引用

页数：8

共 50 条

[1] Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients
Lange, Andrzej
Lange, Janusz
Jaskula, Emilia
FRONTIERS IN IMMUNOLOGY, 2021, 12
[2] Immune dysregulation and system pathology in COVID-19
Jamal, Muhammad
Bangash, Hina Iqbal
Habiba, Maria
Lei, Yufei
Xie, Tian
Sun, Jiaxing
Wei, Zimeng
Hong, Zixi
Shao, Liang
Zhang, Qiuping
VIRULENCE, 2021, 12 (01) : 918 - 936
[3] Comparable bidirectional neutrophil immune dysregulation between Kawasaki disease and severe COVID-19
Chen, Kuang-Den
Huang, Ying-Hsien
Wu, Wei-Sheng
Chang, Ling-Sai
Chu, Chiao-Lun
Kuo, Ho-Chang
FRONTIERS IN IMMUNOLOGY, 2022, 13
[4] COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation
Lee, Abby C.
Castaneda, Grant
Li, Wei Tse
Chen, Chengyu
Shende, Neil
Chakladar, Jaideep
Taub, Pam R.
Chang, Eric Y.
Ongkeko, Weg M.
VIRUSES-BASEL, 2021, 13 (06):
[5] Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
Mazzoni, Alessio
Salvati, Lorenzo
Maggi, Laura
Annunziato, Francesco
Cosmi, Lorenzo
SEMINARS IN IMMUNOLOGY, 2021, 55
[6] Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19
Khwatenge, Collins N.
Pate, Marquette
Miller, Laura C.
Sang, Yongming
FRONTIERS IN IMMUNOLOGY, 2021, 12
[7] Dysregulation of the immune response affects the outcome of critical COVID-19 patients
Wei, Lin-lin
Wang, Wen-jing
Chen, De-xi
Xu, Bin
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (11) : 2768 - 2776
[8] Nanotechnology to the Rescue: Treatment Perspective for the Immune Dysregulation Observed in COVID-19
Peter, Angela E.
Sandeep, B. V.
Rao, B. Ganga
Kalpana, V. Lakshmi
FRONTIERS IN NANOTECHNOLOGY, 2021, 3
[9] COVID-19 and the Immune System
Paces, Jan
Strizova, Zuzana
Smrz, Daniel
Cerny, Jan
PHYSIOLOGICAL RESEARCH, 2020, 69 (03) : 379 - 388
[10] Maternal COVID-19 Disease and COVID-19 Immunization
Sunder, Amala
Varghese, Bessy
Taha, Omer
Keshta, Mohamed S.
Bughamar, Ameena Khalid
Mohamed, Enas Nadir Abelhamid
Fadhulalla, Yusra Mirghani Aljailani
Darwish, Basma
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)

← 1 2 3 4 5 →